Mr. Willson is President & CEO of ITF Pharma, Inc. and is co-founder and chairman of Hsiri Therapeutics, LLC, a start-up company focused on the development of new antibiotics for drug-resistant infections. He was formerly the President & CEO of Cytokine PharmaSciences, Inc., a biopharmaceutical company focused on women’s health, inflammation and cancer. As one of Cytokine founders, Mr. Willson spent 19 years in leadership positions managing the successful development and licensing of several products, including Cervidil, one of the world’s leading obstetric products. In October 2011, Mr. Willson led the company in a strategic sale to Ferring S.A. Before joining Cytokine, Mr. Willson held management, finance and business development positions at Abbott Laboratories Rorer International, and Carrington Laboratories. Mr. Willson graduated summa cum laude from the University of Notre Dame with a degree in psychology and modern languages and has a law degree from the University of California, Hastings College of the Law.